Synoste
Develops treatment solutions for skeletal deformities.
Launch date
Employees
Market cap
-
Enterprise valuation
€20—31m (Dealroom.co estimates Oct 2018.)
Company register number 2493476-4
Espoo Uusimaa (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2018 | 2019 |
|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m |
| % growth | - | 384 % | - | - |
| EBITDA | (<1m) | (<1m) | (<1m) | (<1m) |
| % EBITDA margin | (528 %) | (136 %) | (20750 %) | (45550 %) |
| Profit | (<1m) | (<1m) | (1.3m) | (1.7m) |
| % profit margin | (1586 %) | (335 %) | (65250 %) | (82700 %) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
€230k | Early VC | ||
* | €2.8m | Series A | |
N/A | Early VC | ||
* | €1.0m | Grant | |
* | €1.2m | Series A | |
* | N/A | Series C | |
* | €5.1m | Series D | |
| Total Funding | €10.3m | ||
Related Content
Recent News about Synoste
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.